$34.22
-$1.04 (-2.95%)
$33.82Day Range$35.34
Key Statistics
Market Cap
$1.79B
Shares Outstanding
50.8M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Dec 11, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$34.64
Day High
$35.34
Day Low
$33.82
Volume
146.4K
VWAP
$34.43
Prev Close
$35.26
Transactions
--
Acc. Volume
--
About Nanobiotix S.A. American Depositary Shares
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Identifiers
- CIK
- 0001760854
- Composite FIGI
- BBG00Y9D2SW8
- Share Class FIGI
- BBG00Y9D2TR2
- Ticker Root
- NBTX
About Nanobiotix S.A. American Depositary Shares (NBTX) Stock
Nanobiotix S.A. American Depositary Shares (NBTX) closed the 2026-09-16 session at $34.22, down 2.95% versus the previous close (-1.04). The stock opened at $34.64 and traded between $33.82 and $35.34 during that session. Session trading volume was 146K shares. The volume-weighted average price (VWAP) is $34.43.
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Nanobiotix S.A. American Depositary Shares has a market capitalization of $1.79 billion. NBTX is listed on the XNAS exchange. The company employs approximately 97 people. The recorded listing date is 2020-12-11.
On this page you can find market NBTX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.